Literature DB >> 28993877

Anxiety, Depression, and Health-Related QOL in Patients Diagnosed with PAH or CTEPH.

Elena Pfeuffer1,2, Holger Krannich3, Michael Halank4, Heinrike Wilkens5, Philipp Kolb6, Berthold Jany1, Matthias Held7.   

Abstract

BACKGROUND: Pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) are life-threatening diseases with a high burden of symptoms. Although depression, anxiety, and reduced health related quality of life (HRQOL) have also been reported, a comparative analysis which explores these traits and their underlying factors was lacking.
METHODS: A retrospective analysis of depression, anxiety, and health related QOL was conducted using a Hospital anxiety and depression scale (HADS) as well as the SF-36 HRQOL questionnaire. Results from these tools were compared with haemodynamic and functional parameters in 70 PAH and 23 CTEPH outpatients from a German tertiary care center specializing in pulmonary hypertension.
RESULTS: Although HRQOL was reduced in both cohorts of patients, individuals diagnosed with CTEPH scored lower in nearly all SF-36 parameters. Significance was noted in both "mental health" (p = 0.01) and "mental component summary score" (MCS) (p = 0.02). Depression was also more frequent in patients with CTEPH (56%) than in patients with PAH (30%), (p = 0.03). Overall, depression and anxiety correlated with most SF-36 scales in both PAH and CTEPH. In CTEPH, depression also correlated with the Borg Dyspnea Scale (r = 0.44, p = 0.01). These patients also had significantly lower pCO2 levels than the PAH cohort reflecting more severe ventilation/perfusion mismatch. All other haemodynamic and functional parameters did not differ across the groups.
CONCLUSION: While both cohorts of patients suffer from a reduced HRQOL as well as depression and anxiety, decreases in mental health parameters are more pronounced in the CTEPH cohort. This suggests a strong effort to improve early detection, especially in dyspneic patients with classical risk factors for CTEPH and PAH and argues for mental illness interventions alongside routine clinical care provided to patients diagnosed with PAH or CTEPH.

Entities:  

Keywords:  CTEPH; Depression; Hyperventilation; Mental health; PAH; Pulmonary hypertension; Quality of life

Mesh:

Substances:

Year:  2017        PMID: 28993877     DOI: 10.1007/s00408-017-0052-z

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  61 in total

1.  Pulmonary arterial hypertension in France: results from a national registry.

Authors:  Marc Humbert; Olivier Sitbon; Ari Chaouat; Michèle Bertocchi; Gilbert Habib; Virginie Gressin; Azzedine Yaici; Emmanuel Weitzenblum; Jean-François Cordier; François Chabot; Claire Dromer; Christophe Pison; Martine Reynaud-Gaubert; Alain Haloun; Marcel Laurent; Eric Hachulla; Gérald Simonneau
Journal:  Am J Respir Crit Care Med       Date:  2006-02-02       Impact factor: 21.405

2.  Prognostic factors in medically treated patients with chronic pulmonary embolism.

Authors:  J Lewczuk; P Piszko; J Jagas; A Porada; S Wójciak; B Sobkowicz; K Wrabec
Journal:  Chest       Date:  2001-03       Impact factor: 9.410

3.  Prevalence of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the United States.

Authors:  Noam Y Kirson; Howard G Birnbaum; Jasmina I Ivanova; Tracy Waldman; Vijay Joish; Todd Williamson
Journal:  Curr Med Res Opin       Date:  2011-07-27       Impact factor: 2.580

4.  Measurement of quality of life in pulmonary hypertension and its significance.

Authors:  E Cenedese; R Speich; L Dorschner; S Ulrich; M Maggiorini; R Jenni; M Fischler
Journal:  Eur Respir J       Date:  2006-05-17       Impact factor: 16.671

5.  Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry.

Authors:  Eckhard Mayer; David Jenkins; Jaroslav Lindner; Andrea D'Armini; Jaap Kloek; Bart Meyns; Lars Bo Ilkjaer; Walter Klepetko; Marion Delcroix; Irene Lang; Joanna Pepke-Zaba; Gerald Simonneau; Philippe Dartevelle
Journal:  J Thorac Cardiovasc Surg       Date:  2011-03       Impact factor: 5.209

6.  Prognostic value of anxiety and depression in patients with chronic heart failure.

Authors:  Wei Jiang; Maragatha Kuchibhatla; Michael S Cuffe; Eric J Christopher; Jude D Alexander; Greg L Clary; Michael A Blazing; Laura H Gaulden; Robert M Califf; Ranga R Krishnan; Christopher M O'Connor
Journal:  Circulation       Date:  2004-11-22       Impact factor: 29.690

7.  Health-related quality of life in a national cohort of patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension.

Authors:  Antonio Roman; Joan Albert Barbera; Maria Jesús Castillo; Rocío Muñoz; Pilar Escribano
Journal:  Arch Bronconeumol       Date:  2013-02-27       Impact factor: 4.872

8.  Predictors of depressive symptoms in patients with COPD and health impact.

Authors:  David B Coultas; Drew W Edwards; Bethany Barnett; Peter Wludyka
Journal:  COPD       Date:  2007-03       Impact factor: 2.409

Review 9.  Depression and anxiety in chronic heart failure and chronic obstructive pulmonary disease: prevalence, relevance, clinical implications and management principles.

Authors:  A M Yohannes; T G Willgoss; R C Baldwin; M J Connolly
Journal:  Int J Geriatr Psychiatry       Date:  2010-12       Impact factor: 3.485

10.  Pulmonary hypertension in Portugal: first data from a nationwide registry.

Authors:  Rui Baptista; José Meireles; Ana Agapito; Graça Castro; António Marinho da Silva; Teresa Shiang; Fabienne Gonçalves; Susana Robalo-Martins; António Nunes-Diogo; Abílio Reis
Journal:  Biomed Res Int       Date:  2013-10-21       Impact factor: 3.411

View more
  11 in total

Review 1.  [Functional diagnostics in pneumology].

Authors:  M Held; S Baron; B Jany
Journal:  Internist (Berl)       Date:  2018-01       Impact factor: 0.743

Review 2.  Anxiety and depression in patients with pulmonary hypertension: impact and management challenges.

Authors:  Maurizio Bussotti; Marinella Sommaruga
Journal:  Vasc Health Risk Manag       Date:  2018-11-08

3.  Exploring the experiences and psychosocial stresses of Taiwanese patients with pulmonary hypertension: a qualitative interview study.

Authors:  Yung-Chih Chiang; Li-Yu Hu; Jeremy Couper; Chin-Chang Cheng; Ling-Hsiang Wang; Wei-Chun Huang; Ti Lu
Journal:  Pulm Circ       Date:  2018-06-19       Impact factor: 3.017

Review 4.  Malnutrition in pulmonary arterial hypertension: a possible role for dietary intervention.

Authors:  Chermaine T Kwant; Gerrina Ruiter; Anton Vonk Noordegraaf
Journal:  Curr Opin Pulm Med       Date:  2019-09       Impact factor: 3.155

5.  Effect of Living Environment Factors on Quality of Life in Patients With Chronic Thromboembolic Pulmonary Hypertension After Completion of Balloon Pulmonary Angioplasty - A Cross-Sectional Study.

Authors:  Yosuke Morimoto; Satoshi Ikeda; Yuki Yamagata; Ryo Kozu; Hiroaki Kawano; Koji Maemura
Journal:  Circ Rep       Date:  2021-04-03

6.  Association of daily physical activity with psychosocial aspects and functional capacity in patients with pulmonary arterial hypertension: a cross-sectional study.

Authors:  Layse Nakazato; Felipe Mendes; Ilma A Paschoal; Daniela C Oliveira; Marcos M Moreira; Mônica C Pereira
Journal:  Pulm Circ       Date:  2021-03-29       Impact factor: 3.017

7.  Depression, anxiety and psychological distress in patients with pulmonary hypertension: a mixed-methods study.

Authors:  Yuka Takita; Yuko Takeda; Daisuke Fujisawa; Masaharu Kataoka; Takashi Kawakami; Ardith Z Doorenbos
Journal:  BMJ Open Respir Res       Date:  2021-04

8.  Prevalence, Risk Factors and Intervention for Depression and Anxiety in Pulmonary Hypertension: A Systematic Review and Meta-analysis.

Authors:  Aaron Shengting Mai; Oliver Zi Hern Lim; Yeung Jek Ho; Gwyneth Kong; Grace En Hui Lim; Cheng Han Ng; Cyrus Ho; Roger Ho; Yinghao Lim; Ivandito Kuntjoro; Edgar Tay; James Yip; Nicholas W S Chew; Ting-Ting Low
Journal:  Front Med (Lausanne)       Date:  2022-02-17

9.  Prevalence of Mental Disorders in Patients With Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Madelaine-Rachel Dering; Nicole Lepsy; Jan Fuge; Tanja Meltendorf; Marius M Hoeper; Ivo Heitland; Jan C Kamp; Da-Hee Park; Manuel J Richter; Henning Gall; Hossein A Ghofrani; Dietmar Ellermeier; Hans-Dieter Kulla; Kai G Kahl; Karen M Olsson
Journal:  Front Psychiatry       Date:  2022-03-02       Impact factor: 4.157

10.  INSPIRE: Safety and tolerability of inhaled Yutrepia (treprostinil) in pulmonary arterial hypertension (PAH).

Authors:  Nicholas S Hill; Jeremy P Feldman; Sandeep Sahay; Raymond L Benza; Ioana R Preston; David Badesch; Robert P Frantz; Savan Patel; Ashley Galloway; Todd M Bull
Journal:  Pulm Circ       Date:  2022-07-01       Impact factor: 2.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.